Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29‐month follow‐up from a randomized, open‐label, phase III trial
Article in Cancer Medicine (May 2024)
The most recent citing publications are shown below. View all 490 publications that cite this research output on Dimensions.
Article in Cancer Medicine (May 2024)
Article in Molecular Oncology (May 2024)
Article in Nature Cell Biology (May 2024)